Clinical Trials Directory

Trials / Completed

CompletedNCT01304134

Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving Treatment

A Prospective, Randomized, Blind, Multicentre, Parallel Group Study to Investigate the Efficacy and Safety of Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving Treatment

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
240 (actual)
Sponsor
Mundipharma (China) Pharmaceutical Co. Ltd · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

To determine the efficacy and safety of oxycodone i.v. patient-controlled analgesia (PCA) in the pain relieving treatment during 48h postoperative period, by comparing with morphine i.v. PCA.

Conditions

Interventions

TypeNameDescription
DRUGOxycodonedosage:10mg/l dosage form:injection frequency:via PCA pump, background rate:0.5ml/h, 2ml/time duration:48 hours
DRUGMorphinedosage: 10mg/ml dosage form: injection frequency: via PCA pump, background rate: 0.5ml/h, 2ml/times duration: 48 hours

Timeline

Start date
2010-03-01
Primary completion
2010-08-01
Completion
2010-08-01
First posted
2011-02-25
Last updated
2015-08-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01304134. Inclusion in this directory is not an endorsement.

Oxycodone Hydrochloride Injection in the Postoperative Pain Relieving Treatment (NCT01304134) · Clinical Trials Directory